Bioatla Common Stock Total Equity from 2010 to 2026
| BCAB Stock | USD 0.14 0 0.86% |
Common Stock Total Equity | First Reported 2010-12-31 | Previous Quarter 4.5 K | Current Value 4.3 K | Quarterly Volatility 378.2 K |
Check Bioatla financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioatla's main balance sheet or income statement drivers, such as Net Interest Income of 4.1 M, Interest Income of 4.1 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 2.23, Dividend Yield of 0.0 or PTB Ratio of 1.9. Bioatla financial statements analysis is a perfect complement when working with Bioatla Valuation or Volatility modules.
Bioatla | Common Stock Total Equity | Build AI portfolio with Bioatla Stock |
Analyzing Bioatla's Common Stock Total Equity over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Common Stock Total Equity has evolved provides context for assessing Bioatla's current valuation and future prospects.
Latest Bioatla's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Bioatla over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Bioatla's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioatla's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Bioatla Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 442,987 | |
| Geometric Mean | 89,863 | |
| Coefficient Of Variation | 85.39 | |
| Mean Deviation | 361,192 | |
| Median | 750,000 | |
| Standard Deviation | 378,245 | |
| Sample Variance | 143.1B | |
| Range | 747K | |
| R-Value | (0.85) | |
| Mean Square Error | 41.4B | |
| R-Squared | 0.73 | |
| Significance | 0.000013 | |
| Slope | (63,949) | |
| Total Sum of Squares | 2.3T |
Bioatla Common Stock Total Equity History
About Bioatla Financial Statements
Bioatla stakeholders use historical fundamental indicators, such as Bioatla's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Bioatla investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bioatla's assets and liabilities are reflected in the revenues and expenses on Bioatla's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bioatla. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 4.5 K | 4.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:Check out the analysis of Bioatla Correlation against competitors. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. Projected growth potential of Bioatla fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Bioatla assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bioatla's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bioatla should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bioatla's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.